Clinical Trial Update: CardioMEMS HF System Real-World Evidence Post-Approval Study

View source ↗

Summary

Update on the CardioMEMS HF System real-world evidence post-approval study; the trial is currently enrolling by invitation to evaluate real-world outcomes in he…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Snippet

Sponsor: Abbott Medical Devices | Conditions: Heart Failure NYHA Class II, Heart Failure NYHA Class III | Status: ENROLLING_BY_INVITATION